| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | DAPK1 | 3.78e-07 | 3 | 136 | 3 | IPR020676 | |
| Domain | VWF_A | 6.30e-07 | 99 | 136 | 8 | IPR002035 | |
| Domain | - | 1.65e-05 | 74 | 136 | 6 | 3.40.50.410 | |
| Domain | VWFA | 2.97e-05 | 82 | 136 | 6 | PS50234 | |
| Domain | VWA | 3.40e-05 | 84 | 136 | 6 | SM00327 | |
| Domain | ARM-type_fold | CAND1 CLTCL1 IPO4 MEI1 AP3B1 RYR3 AP2A1 XPO6 RPTOR INTS4 UNC79 | 3.87e-05 | 339 | 136 | 11 | IPR016024 |
| Domain | VWA | 5.39e-05 | 56 | 136 | 5 | PF00092 | |
| Domain | HEAT | 4.08e-04 | 48 | 136 | 4 | PF02985 | |
| Domain | DS_RBD | 4.56e-04 | 21 | 136 | 3 | PS50137 | |
| Domain | Aminotrans_3 | 5.19e-04 | 5 | 136 | 2 | IPR005814 | |
| Domain | Aminotran_3 | 5.19e-04 | 5 | 136 | 2 | PF00202 | |
| Domain | AA_TRANSFER_CLASS_3 | 5.19e-04 | 5 | 136 | 2 | PS00600 | |
| Pubmed | CAND1 IARS1 BAG2 SPAG9 IPO4 AP3B1 ADAR DHX9 ESYT2 SEC24C DDX18 NUP210 DLAT SCFD1 USP39 PLS3 XRCC6 KDM1A SYNCRIP | 1.75e-11 | 638 | 142 | 19 | 33239621 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | CAND1 ANK1 IARS1 BAG2 IPO4 RREB1 AP3B1 ADAR LAP3 DHX9 PHF2 ESYT2 IGF2BP2 SEC24C AP2A1 USP42 BAZ2A DDX18 IQSEC1 DDX23 ALDH4A1 SCFD1 PPIP5K2 XRCC6 KDM1A SYNCRIP | 2.52e-11 | 1318 | 142 | 26 | 30463901 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RAF1 PITRM1 VWA8 MRPL44 BAG2 DAPK3 TACC2 SPAG9 ARMCX4 DHX9 SLC30A6 ESYT2 IGF2BP2 ALMS1 BAZ2A RPTOR DDX18 DLAT ALDH4A1 SCFD1 GFM1 YME1L1 DDX28 XRCC6 RBFA SYNCRIP | 3.87e-10 | 1496 | 142 | 26 | 32877691 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RAF1 CAND1 FNTA IARS1 BAG2 SPAG9 IPO4 AP3B1 ADAR LAP3 DHX9 IGF2BP2 AP2A1 SVIL AGFG1 DLAT SCFD1 USP39 PLS3 XRCC6 GOT1 SYNCRIP | 1.78e-09 | 1149 | 142 | 22 | 35446349 |
| Pubmed | CAND1 CLTCL1 MED16 IARS1 CYP20A1 IPO4 ECE1 AP3B1 IFI16 ADAR BTN3A2 DHX9 ESYT2 AGO4 AP2A1 PRIM1 DDX18 NUP210 IQSEC1 YME1L1 XRCC6 SYNCRIP | 2.40e-09 | 1168 | 142 | 22 | 19946888 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CAND1 VWA8 MED16 MRPL44 ADAR DHX9 PHF2 IGF2BP2 SEC24C AP2A1 USP42 VCAN DDX18 IQSEC1 ZNF638 INTS4 DDX23 USP39 PPIP5K2 XRCC6 SYNCRIP | 3.41e-09 | 1082 | 142 | 21 | 38697112 |
| Pubmed | CAND1 FNTA IARS1 MRPL44 BAG2 IPO4 ADAR DHX9 IGF2BP2 HMCN2 SEC24C AP2A1 PRIM1 ZNF638 DLAT SCFD1 YME1L1 PLS3 DDX28 XRCC6 KDM1A RBFA SYNCRIP | 5.36e-09 | 1335 | 142 | 23 | 29229926 | |
| Pubmed | CAND1 PITRM1 POU2F1 AP3B1 ADAR ESYT2 DLAT USP39 ZNF606 PLS3 XRCC6 WNK3 GOT1 SYNCRIP | 5.52e-09 | 451 | 142 | 14 | 36168627 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BAG2 TOPBP1 RREB1 IFI16 ADAR DHX9 PHF2 ESYT2 BRCA1 AP2A1 USP42 BAZ2A DDX18 EXO1 ZNF638 INTS4 DDX23 USP39 TMEM41B XRCC6 KDM1A SYNCRIP | 1.52e-08 | 1294 | 142 | 22 | 30804502 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | CAND1 PITRM1 IARS1 MRPL44 IPO4 AP3B1 ADAR LAP3 DHX9 PHF2 AP2A1 RPTOR PRIM1 DDX18 NUP210 DLAT SCFD1 USP39 GFM1 PLS3 XRCC6 KDM1A SYNCRIP | 1.79e-08 | 1425 | 142 | 23 | 30948266 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | POU2F1 SPAG9 RREB1 IFI16 DHX9 ESYT2 SEC24C USP42 BAZ2A XPO6 RPTOR SVIL IQSEC1 EXO1 ZNF638 SCFD1 XRCC6 | 2.05e-08 | 774 | 142 | 17 | 15302935 |
| Pubmed | RAF1 VWA8 HAUS5 BAG2 CLSTN2 RREB1 PHF2 ARHGAP4 IGF2BP2 HMCN2 ALMS1 BRCA1 BAZ2A RPTOR DDX18 IQSEC1 DLAT YME1L1 KDM1A SORL1 | 3.12e-08 | 1116 | 142 | 20 | 31753913 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 IARS1 BAG2 IPO4 IFI16 ADAR DHX9 IGF2BP2 SEC24C AP2A1 BAZ2A RPTOR DDX18 IQSEC1 ZNF638 DDX23 DLAT SCFD1 YME1L1 XRCC6 KDM1A SYNCRIP | 3.34e-08 | 1353 | 142 | 22 | 29467282 |
| Pubmed | The death-associated protein kinases: structure, function, and beyond. | 6.66e-08 | 3 | 142 | 3 | 16756490 | |
| Pubmed | BAG2 TOPBP1 ADAR DHX9 BRCA1 DDX18 SVIL NUP210 ZNF638 DDX23 USP39 PLS3 XRCC6 KDM1A SYNCRIP | 8.08e-08 | 652 | 142 | 15 | 31180492 | |
| Pubmed | VWA8 RANBP3 MRPL44 IPO4 AP3B1 ADAR ESYT2 AP2A1 RPTOR INTS4 DDX23 DLAT GFM1 KDM1A | 8.16e-08 | 560 | 142 | 14 | 35241646 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CAND1 MED16 MRPL44 TOPBP1 TACC2 ADAR DHX9 IGF2BP2 AP2A1 DDX18 EXO1 DLAT YME1L1 DDX28 XRCC6 SYNCRIP | 9.59e-08 | 759 | 142 | 16 | 35915203 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CAND1 IARS1 HAUS5 BAG2 ADAR DHX9 IGF2BP2 SEC24C AP2A1 DDX18 SVIL NUP210 ZNF638 DDX23 USP39 XRCC6 KDM1A SYNCRIP | 2.15e-07 | 1024 | 142 | 18 | 24711643 |
| Pubmed | CAND1 IARS1 BAG2 IPO4 DHX9 ESYT2 IGF2BP2 SEC24C AP2A1 DDX18 NUP210 AGFG1 USP39 XRCC6 SYNCRIP | 2.28e-07 | 707 | 142 | 15 | 19738201 | |
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 2.66e-07 | 4 | 142 | 3 | 39142074 | |
| Pubmed | FLVCR1 BAG2 DAPK3 GPRIN3 CTDSP1 SPAG9 BCAR1 AP3B1 PHF2 ESYT2 IGF2BP2 PPP3CC PRIM1 SVIL NUP210 ZNF638 INTS4 YME1L1 | 3.06e-07 | 1049 | 142 | 18 | 27880917 | |
| Pubmed | RAF1 CAND1 IARS1 MRPL44 PNKD ADAR DHX9 ESYT2 IGF2BP2 DDX18 NUP210 USP39 GFM1 XRCC6 SYNCRIP | 3.13e-07 | 725 | 142 | 15 | 27025967 | |
| Pubmed | 3.19e-07 | 159 | 142 | 8 | 22751105 | ||
| Pubmed | 3.60e-07 | 36 | 142 | 5 | 24147044 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RAF1 PITRM1 IARS1 SPAG9 IPO4 RREB1 AP3B1 DHX9 AP2A1 XPO6 RPTOR ZNF638 TMEM41B PPIP5K2 YME1L1 PLS3 TRAPPC9 KDM1A SYNCRIP SORL1 | 4.64e-07 | 1321 | 142 | 20 | 27173435 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | RAF1 RANBP3 DAPK2 DAPK3 BCAR1 ESYT2 ALMS1 RPTOR SVIL IQSEC1 AGFG1 EXO1 PPIP5K2 TRAPPC9 WNK3 SPATA13 | 5.16e-07 | 861 | 142 | 16 | 36931259 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RAF1 CAND1 PITRM1 FNTA SPAG9 IPO4 AP3B1 ESYT2 IGF2BP2 AP2A1 NUP210 GFM1 YME1L1 PLS3 KDM1A SYNCRIP SORL1 | 5.30e-07 | 974 | 142 | 17 | 28675297 |
| Pubmed | ANK2 VWA8 RANBP3 FLVCR1 MRPL44 BAG2 IPO4 AP3B1 DHX9 ESYT2 SEC24C BAZ2A DDX18 NUP210 DDX23 DLAT SCFD1 YME1L1 PLS3 XRCC6 SYNCRIP | 7.18e-07 | 1487 | 142 | 21 | 33957083 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DSG3 IARS1 DAPK3 IPO4 IFI16 ADAR ITIH2 DHX9 IGF2BP2 AP2A1 PRIM1 DDX18 SVIL NUP210 ZNF638 USP39 PLS3 XRCC6 SYNCRIP | 9.46e-07 | 1257 | 142 | 19 | 36526897 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | CAND1 CLTCL1 IARS1 DAPK1 GPRIN3 CLSTN2 IPO4 AP3B1 DHX9 AP2A1 DDX18 UNC79 HYDIN XRCC6 SYNCRIP | 1.19e-06 | 807 | 142 | 15 | 30575818 |
| Pubmed | IARS1 MRPL44 HAUS5 DHX9 ESYT2 SEC24C BAZ2A DDX18 DLAT USP39 PLS3 XRCC6 KDM1A RBFA SYNCRIP | 1.23e-06 | 809 | 142 | 15 | 32129710 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | FNTA DAPK3 LAP3 DHX9 IGF2BP2 PRIM1 AGFG1 ALDH4A1 ALDH6A1 YME1L1 PLS3 DDX28 XRCC6 SYNCRIP | 1.26e-06 | 704 | 142 | 14 | 32994395 |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | PHYKPL RFK PITRM1 FPGS MRPL44 IREB2 PNKD LAP3 SLC30A6 AGXT2 DLAT ALDH4A1 GFM1 ALDH6A1 YME1L1 DDX28 | 1.34e-06 | 926 | 142 | 16 | 20877624 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | CAND1 IARS1 ADAR SVEP1 DHX9 IGF2BP2 DDX23 DLAT USP39 ALDH6A1 XRCC6 KDM1A GOT1 SYNCRIP | 1.49e-06 | 714 | 142 | 14 | 28302793 |
| Pubmed | PITRM1 IARS1 MRPL44 BAG2 POU2F1 SPAG9 RREB1 PHF2 IGF2BP2 ALMS1 BRCA1 DDX18 SVIL ZNF638 DLAT TRAPPC9 XRCC6 KDM1A SYNCRIP SORL1 | 1.56e-06 | 1429 | 142 | 20 | 35140242 | |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.83e-06 | 89 | 142 | 6 | 22446626 | |
| Pubmed | CAND1 ANK2 DAPK1 DAPK3 ARMCX4 IPO4 SEC24C AP2A1 RPTOR SVIL IQSEC1 UNC79 XRCC6 WNK3 KDM1A SPATA13 | 2.21e-06 | 963 | 142 | 16 | 28671696 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 23071094 | ||
| Pubmed | VWA8 IARS1 ECE1 MMP24 SEC24C DDX18 NUP210 ZNF638 MEDAG DDX23 TMEM41B YME1L1 XRCC6 KDM1A | 2.80e-06 | 754 | 142 | 14 | 35906200 | |
| Pubmed | SPAG9 IPO4 IGF2BP2 SEC24C BAZ2A DDX18 NUP210 ZNF638 DDX23 DLAT XRCC6 KDM1A SYNCRIP | 3.05e-06 | 653 | 142 | 13 | 22586326 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | BAG2 IPO4 ADAR LAP3 DHX9 SEC24C USP42 DDX18 ZNF638 DDX23 DLAT USP39 GFM1 XRCC6 KDM1A SYNCRIP | 3.10e-06 | 989 | 142 | 16 | 36424410 |
| Pubmed | CAND1 PITRM1 IARS1 CYP20A1 SPAG9 IPO4 LAP3 DHX9 SEC24C AP2A1 DDX18 AGFG1 DLAT PLS3 XRCC6 | 3.35e-06 | 878 | 142 | 15 | 37223481 | |
| Pubmed | RAF1 ANK2 VWA8 IREB2 AP3B1 ITIH2 ITIH3 PHF2 IGF2BP2 SEC24C AP2A1 DDX18 SVIL IQSEC1 DDX23 DLAT PLS3 DDX28 XRCC6 | 3.36e-06 | 1371 | 142 | 19 | 36244648 | |
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 15723802 | ||
| Pubmed | 4.43e-06 | 59 | 142 | 5 | 32382008 | ||
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | 5.24e-06 | 231 | 142 | 8 | 36597993 | |
| Pubmed | CAND1 PITRM1 IARS1 ADAR DHX9 SEC24C DLAT SCFD1 GFM1 PLS3 SYNCRIP | 5.25e-06 | 484 | 142 | 11 | 31995728 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RAF1 FNTA IARS1 RANBP3 PCDHB5 MRPL44 BAG2 SPAG9 IPO4 AP3B1 DHX9 IGF2BP2 XPO6 DDX23 USP39 UNC79 PLS3 SYNCRIP | 5.32e-06 | 1284 | 142 | 18 | 17353931 |
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 28115467 | ||
| Pubmed | RAF1 CAND1 ANK2 IARS1 DAPK1 DAPK3 AP3B1 DHX9 SEC24C AP2A1 RPTOR VCAN SVIL IQSEC1 DLAT PLS3 TRAPPC9 GOT1 SYNCRIP | 6.21e-06 | 1431 | 142 | 19 | 37142655 | |
| Pubmed | CAND1 IARS1 SPAG9 DHX9 ALMS1 SEC24C BRCA1 RPTOR XRCC6 KDM1A SYNCRIP | 6.37e-06 | 494 | 142 | 11 | 26831064 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 6.54e-06 | 316 | 142 | 9 | 31665637 | |
| Pubmed | 7.15e-06 | 241 | 142 | 8 | 23125841 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | CAND1 IARS1 FLVCR1 BAG2 IPO4 AP3B1 ESYT2 AP2A1 XPO6 RPTOR NUP210 SCFD1 TMEM41B YME1L1 WNK3 | 7.77e-06 | 942 | 142 | 15 | 31073040 |
| Pubmed | 8.06e-06 | 245 | 142 | 8 | 35652658 | ||
| Pubmed | MRPL44 TOPBP1 DAPK1 DHX9 IGF2BP2 USP42 DDX18 DENND2C INTS4 DDX23 USP39 DDX28 XRCC6 | 9.08e-06 | 723 | 142 | 13 | 34133714 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 9.90e-06 | 119 | 142 | 6 | 35776542 | |
| Pubmed | 1.17e-05 | 340 | 142 | 9 | 24332808 | ||
| Pubmed | CAND1 PITRM1 VWA8 HAUS5 TOPBP1 ARHGAP4 AGO4 RPTOR SCFD1 PPIP5K2 KDM1A | 1.21e-05 | 529 | 142 | 11 | 14621295 | |
| Pubmed | RAF1 CAND1 VWA8 BAG2 DHX9 SEC24C BRCA1 AP2A1 SVIL YME1L1 XRCC6 SYNCRIP | 1.23e-05 | 634 | 142 | 12 | 34591612 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 1.58e-05 | 353 | 142 | 9 | 27545878 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 31116076 | ||
| Pubmed | Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells. | 1.66e-05 | 2 | 142 | 2 | 22160140 | |
| Pubmed | DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome. | 1.66e-05 | 2 | 142 | 2 | 28355180 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22606311 | ||
| Pubmed | Attenuation of EPO-dependent erythroblast formation by death-associated protein kinase-2. | 1.66e-05 | 2 | 142 | 2 | 18535204 | |
| Pubmed | Both DNA topoisomerase II-binding protein 1 and BRCA1 regulate the G2-M cell cycle checkpoint. | 1.66e-05 | 2 | 142 | 2 | 12810625 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 29330289 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 26100670 | ||
| Pubmed | A high-resolution genetic map of the nervous locus on mouse chromosome 8. | 1.66e-05 | 2 | 142 | 2 | 9545640 | |
| Pubmed | EXO1 protects BRCA1-deficient cells against toxic DNA lesions. | 1.66e-05 | 2 | 142 | 2 | 38266640 | |
| Pubmed | Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer. | 1.66e-05 | 2 | 142 | 2 | 18000219 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23610439 | ||
| Pubmed | Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. | 1.66e-05 | 2 | 142 | 2 | 21918970 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22846996 | ||
| Pubmed | BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. | 1.66e-05 | 2 | 142 | 2 | 9662397 | |
| Pubmed | Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice. | 1.66e-05 | 2 | 142 | 2 | 8471772 | |
| Pubmed | DHX9-dependent recruitment of BRCA1 to RNA promotes DNA end resection in homologous recombination. | 1.66e-05 | 2 | 142 | 2 | 34226554 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21113407 | ||
| Pubmed | Induction of Viral Mimicry Upon Loss of DHX9 and ADAR1 in Breast Cancer Cells. | 1.66e-05 | 2 | 142 | 2 | 38530197 | |
| Pubmed | A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation. | 1.66e-05 | 2 | 142 | 2 | 25684206 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.67e-05 | 271 | 142 | 8 | 32433965 | |
| Pubmed | Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. | RFK PITRM1 VWA8 FPGS MRPL44 PNKD ADAR LAP3 AGXT2 DLAT ALDH4A1 GFM1 ALDH6A1 YME1L1 DDX28 RBFA | 1.74e-05 | 1136 | 142 | 16 | 34800366 |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 1.87e-05 | 454 | 142 | 10 | 33226137 | |
| Pubmed | CAND1 FLVCR1 GPRIN3 SPAG9 IPO4 AP3B1 DHX9 SLC30A6 SEC24C BRCA1 DDX18 ZNF638 SCFD1 | 1.94e-05 | 777 | 142 | 13 | 35844135 | |
| Pubmed | 2.06e-05 | 202 | 142 | 7 | 24639526 | ||
| Pubmed | CLTCL1 IARS1 MRPL44 AP3B1 DHX9 PHF2 IGF2BP2 AP2A1 RPTOR DDX18 NUP210 SCFD1 PLS3 XRCC6 SPATA13 SYNCRIP | 2.08e-05 | 1153 | 142 | 16 | 29845934 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | CAND1 SPAG9 LAP3 ESYT2 ALMS1 BRCA1 PRIM1 DDX18 DDX23 USH2A XRCC6 KDM1A | 2.11e-05 | 670 | 142 | 12 | 22990118 |
| Pubmed | 2.13e-05 | 203 | 142 | 7 | 35012549 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | MRPL44 BAG2 ADAR IGF2BP2 AGO4 ZNF638 INTS4 WNK3 KDM1A SYNCRIP | 2.17e-05 | 462 | 142 | 10 | 31138677 |
| Pubmed | 2.17e-05 | 40 | 142 | 4 | 16210410 | ||
| Pubmed | Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. | 2.52e-05 | 84 | 142 | 5 | 19135240 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | PHYKPL RFK PITRM1 FPGS IREB2 PNKD LAP3 SLC30A6 AGXT2 DLAT ALDH4A1 GFM1 ALDH6A1 YME1L1 DDX28 | 2.66e-05 | 1047 | 142 | 15 | 18614015 |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | VWA8 MRPL44 BAG2 DAPK1 SPAG9 BCAR1 DHX9 PHF2 IGF2BP2 GLRB ZNF638 DDX28 XRCC6 SYNCRIP | 2.67e-05 | 922 | 142 | 14 | 27609421 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CAND1 FNTA IARS1 RANBP3 BAG2 IREB2 SPAG9 BCAR1 IPO4 AP3B1 LAP3 DHX9 SEC24C AGFG1 PLS3 XRCC6 GOT1 SYNCRIP | 2.84e-05 | 1455 | 142 | 18 | 22863883 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CAND1 AP3B1 DHX9 SEC24C XPO6 ZNF638 DDX23 USP39 XRCC6 KDM1A SYNCRIP | 2.90e-05 | 582 | 142 | 11 | 20467437 |
| Pubmed | 2.99e-05 | 383 | 142 | 9 | 29331416 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | IPO4 AP3B1 ADAR LAP3 DHX9 IGF2BP2 SEC24C AP2A1 ALDH4A1 SCFD1 YME1L1 KDM1A | 3.42e-05 | 704 | 142 | 12 | 29955894 |
| Pubmed | 3.44e-05 | 390 | 142 | 9 | 17643375 | ||
| Pubmed | 3.52e-05 | 90 | 142 | 5 | 31280863 | ||
| Interaction | H2AC4 interactions | CAND1 IARS1 POU2F1 BCAR1 AP3B1 DHX9 ACE2 ALMS1 SEC24C BRCA1 DDX18 SVIL LRRC27 ZNF638 DDX23 UNC79 XRCC6 SYNCRIP | 1.64e-08 | 506 | 141 | 18 | int:H2AC4 |
| Interaction | CIT interactions | RAF1 CLTCL1 VWA8 IARS1 DAPK2 BAG2 DAPK3 RREB1 IFI16 ADAR DHX9 PHF2 ACE2 IGF2BP2 ALMS1 SEC24C BRCA1 AP2A1 DDX18 SVIL NUP210 ZNF638 INTS4 DDX23 USP39 PLS3 DDX28 XRCC6 KDM1A SYNCRIP | 6.25e-08 | 1450 | 141 | 30 | int:CIT |
| Interaction | KIF20A interactions | RAF1 CLTCL1 ANK2 VWA8 IARS1 HAUS5 BAG2 SPAG9 IFI16 ADAR DHX9 ACE2 IGF2BP2 AGO4 ALMS1 BRCA1 AP2A1 DDX18 SVIL ZNF638 YME1L1 DDX28 XRCC6 SYNCRIP | 2.85e-07 | 1052 | 141 | 24 | int:KIF20A |
| Interaction | SCARNA22 interactions | 1.80e-06 | 118 | 141 | 8 | int:SCARNA22 | |
| Interaction | BAP1 interactions | RAF1 CAND1 FNTA IARS1 BAG2 SPAG9 IPO4 AP3B1 ADAR LAP3 DHX9 IGF2BP2 BRCA1 AP2A1 SVIL AGFG1 EXO1 DLAT SCFD1 USP39 PLS3 XRCC6 KDM1A GOT1 SYNCRIP | 4.28e-06 | 1314 | 141 | 25 | int:BAP1 |
| Interaction | NR2C2 interactions | CAND1 ANK1 IARS1 BAG2 IPO4 RREB1 AP3B1 ADAR LAP3 DHX9 PHF2 ESYT2 IGF2BP2 SEC24C AP2A1 USP42 BAZ2A DDX18 IQSEC1 DDX23 ALDH4A1 SCFD1 PPIP5K2 XRCC6 KDM1A SYNCRIP | 4.30e-06 | 1403 | 141 | 26 | int:NR2C2 |
| Interaction | STIP1 interactions | CAND1 IARS1 BAG2 POU2F1 SPAG9 IPO4 AP3B1 ADAR DHX9 ESYT2 SEC24C BRCA1 DDX18 NUP210 DLAT SCFD1 USP39 PLS3 XRCC6 KDM1A SYNCRIP | 6.92e-06 | 1006 | 141 | 21 | int:STIP1 |
| Interaction | C9orf78 interactions | VWA8 RANBP3 MRPL44 BCAR1 IPO4 AP3B1 ADAR ESYT2 AP2A1 RPTOR INTS4 DDX23 DLAT USP39 GFM1 KDM1A | 7.27e-06 | 620 | 141 | 16 | int:C9orf78 |
| Interaction | ARHGAP24 interactions | CAND1 PITRM1 POU2F1 AP3B1 ADAR ESYT2 DLAT USP39 ZNF606 PLS3 XRCC6 WNK3 GOT1 SYNCRIP | 8.25e-06 | 486 | 141 | 14 | int:ARHGAP24 |
| Interaction | GTF3C4 interactions | 9.63e-06 | 195 | 141 | 9 | int:GTF3C4 | |
| Interaction | RBBP8 interactions | 2.42e-05 | 122 | 141 | 7 | int:RBBP8 | |
| Interaction | TIA1 interactions | 2.44e-05 | 275 | 141 | 10 | int:TIA1 | |
| Interaction | SSRP1 interactions | RAF1 CAND1 IFI16 ADAR DHX9 PHF2 ACE2 SEC24C BRCA1 EXO1 ZNF638 INTS4 DDX23 USP39 XRCC6 SYNCRIP | 2.48e-05 | 685 | 141 | 16 | int:SSRP1 |
| Interaction | LARP7 interactions | RAF1 CAND1 CLTCL1 IARS1 MRPL44 BAG2 SPAG9 AP3B1 IFI16 DHX9 PHF2 ACE2 IGF2BP2 BRCA1 BAZ2A DDX18 NUP210 DDX23 XRCC6 SPATA13 SYNCRIP | 3.14e-05 | 1113 | 141 | 21 | int:LARP7 |
| Interaction | CSDE1 interactions | RAF1 CAND1 BAG2 DHX9 ACE2 IGF2BP2 SEC24C BRCA1 XRCC6 SYNCRIP | 3.21e-05 | 284 | 141 | 10 | int:CSDE1 |
| Interaction | METTL17 interactions | RAF1 PHYKPL PITRM1 VWA8 MRPL44 IGF2BP2 DLAT ALDH4A1 GFM1 DDX28 RBFA SYNCRIP | 3.29e-05 | 411 | 141 | 12 | int:METTL17 |
| Interaction | WWOX interactions | CAND1 DSG3 IARS1 BAG2 FRS3 CTDSP1 DHX9 ESYT2 IGF2BP2 SEC24C BRCA1 IQSEC1 DLAT USP39 KDM1A | 3.44e-05 | 627 | 141 | 15 | int:WWOX |
| Interaction | RBM14 interactions | RAF1 CAND1 AP3B1 IFI16 ADAR DHX9 ACE2 IGF2BP2 AATK BRCA1 DDX18 ZNF638 XRCC6 SYNCRIP | 3.46e-05 | 553 | 141 | 14 | int:RBM14 |
| Interaction | ALYREF interactions | RAF1 CAND1 CLTCL1 GRK5 IREB2 DHX9 ACE2 SEC24C BRCA1 DDX23 XRCC6 SYNCRIP | 3.70e-05 | 416 | 141 | 12 | int:ALYREF |
| Interaction | IFI16 interactions | IFI16 ADAR DHX9 IGF2BP2 BRCA1 BAZ2A DDX18 SVIL ZNF638 DDX23 DLAT USP39 PLS3 DDX28 XRCC6 SYNCRIP | 4.09e-05 | 714 | 141 | 16 | int:IFI16 |
| Interaction | RECQL4 interactions | CAND1 FNTA IARS1 MRPL44 BAG2 IPO4 ADAR DHX9 IGF2BP2 HMCN2 SEC24C BRCA1 AP2A1 PRIM1 ZNF638 DLAT SCFD1 YME1L1 PLS3 DDX28 XRCC6 KDM1A RBFA SYNCRIP | 4.35e-05 | 1412 | 141 | 24 | int:RECQL4 |
| Interaction | SART3 interactions | 4.56e-05 | 296 | 141 | 10 | int:SART3 | |
| Interaction | ECT2 interactions | CAND1 CLTCL1 IARS1 DAPK2 BAG2 SPAG9 DHX9 ESYT2 IGF2BP2 SVIL NUP210 DDX23 GFM1 PLS3 DDX28 XRCC6 KDM1A SYNCRIP | 4.82e-05 | 887 | 141 | 18 | int:ECT2 |
| Interaction | NAT10 interactions | 5.39e-05 | 302 | 141 | 10 | int:NAT10 | |
| Interaction | GAK interactions | 5.64e-05 | 189 | 141 | 8 | int:GAK | |
| Interaction | LGALS9 interactions | CAND1 PITRM1 IARS1 ECE1 ADAR DHX9 SEC24C DLAT SCFD1 USP39 GFM1 PLS3 SYNCRIP SORL1 | 6.69e-05 | 588 | 141 | 14 | int:LGALS9 |
| Interaction | SAFB2 interactions | 7.03e-05 | 195 | 141 | 8 | int:SAFB2 | |
| Interaction | TARDBP interactions | RAF1 CAND1 MED16 MRPL44 BAG2 ADAR DHX9 ACE2 IGF2BP2 BRCA1 ATP1B2 XRCC6 SYNCRIP | 7.56e-05 | 520 | 141 | 13 | int:TARDBP |
| Interaction | SPDL1 interactions | 7.66e-05 | 315 | 141 | 10 | int:SPDL1 | |
| Interaction | AP2A2 interactions | 8.10e-05 | 199 | 141 | 8 | int:AP2A2 | |
| Interaction | MECP2 interactions | RAF1 CAND1 VWA8 MED16 MRPL44 ADAR DHX9 PHF2 IGF2BP2 SEC24C AP2A1 USP42 VCAN DDX18 IQSEC1 ZNF638 INTS4 DDX23 USP39 PPIP5K2 XRCC6 SYNCRIP | 8.71e-05 | 1287 | 141 | 22 | int:MECP2 |
| Interaction | ABI3BP interactions | 9.11e-05 | 13 | 141 | 3 | int:ABI3BP | |
| Interaction | FN1 interactions | RAF1 CAND1 IARS1 BAG2 IPO4 ITIH2 DHX9 ACE2 ESYT2 IGF2BP2 SEC24C AP2A1 DDX18 NUP210 USP39 XRCC6 SYNCRIP | 9.21e-05 | 848 | 141 | 17 | int:FN1 |
| Interaction | YWHAQ interactions | RAF1 GRK5 DAPK1 DAPK3 SPAG9 BCAR1 IFI16 DHX9 ACE2 BRCA1 USP42 RPTOR SVIL DENND2C AGFG1 EXO1 ZNF638 PPIP5K2 UNC79 SPATA13 | 1.03e-04 | 1118 | 141 | 20 | int:YWHAQ |
| Interaction | EP300 interactions | ROBO4 CAND1 CLTCL1 ANK1 BAG2 TACC2 SPAG9 IPO4 AP3B1 IFI16 ADAR ITIH3 DHX9 ESYT2 SEC24C BRCA1 AP2A1 RPTOR DDX18 POLI DDX23 XRCC6 KDM1A | 1.08e-04 | 1401 | 141 | 23 | int:EP300 |
| Interaction | TOP1 interactions | RAF1 CAND1 FNTA IFI16 ADAR DHX9 ACE2 BRCA1 PRIM1 EXO1 ZNF638 DDX23 USP39 XRCC6 SYNCRIP | 1.11e-04 | 696 | 141 | 15 | int:TOP1 |
| Interaction | DLAT interactions | 1.19e-04 | 269 | 141 | 9 | int:DLAT | |
| Interaction | AGO2 interactions | RAF1 CAND1 IFI16 DHX9 ESYT2 IGF2BP2 AGO4 BRCA1 AP2A1 IQSEC1 XRCC6 SYNCRIP | 1.23e-04 | 472 | 141 | 12 | int:AGO2 |
| Interaction | MSH6 interactions | 1.26e-04 | 271 | 141 | 9 | int:MSH6 | |
| Interaction | RAN interactions | RAF1 IARS1 RANBP3 BCAR1 IPO4 ACE2 BRCA1 XPO6 RPTOR NUP210 XRCC6 KDM1A | 1.31e-04 | 475 | 141 | 12 | int:RAN |
| Interaction | CCT8 interactions | RAF1 IARS1 IFI16 ACE2 BRCA1 RPTOR TMEM41B YME1L1 PLS3 XRCC6 KDM1A GOT1 NSMAF | 1.32e-04 | 550 | 141 | 13 | int:CCT8 |
| Interaction | RUFY1 interactions | CAND1 FNTA IARS1 VSIG1 IPO4 DHX9 ESYT2 BRCA1 GLRA2 YME1L1 XRCC6 KDM1A | 1.33e-04 | 476 | 141 | 12 | int:RUFY1 |
| Interaction | TRMT10C interactions | 1.38e-04 | 215 | 141 | 8 | int:TRMT10C | |
| Interaction | SF3A3 interactions | CAND1 RANBP3 BAG2 IFI16 ACE2 BRCA1 ZNF638 DDX23 KDM1A SYNCRIP | 1.43e-04 | 340 | 141 | 10 | int:SF3A3 |
| Interaction | METTL14 interactions | COL6A3 CLTCL1 BAG2 SPAG9 ADAR RYR3 DHX9 AP2A1 NUP210 DLAT USH2A XRCC6 SYNCRIP | 1.52e-04 | 558 | 141 | 13 | int:METTL14 |
| Interaction | F2 interactions | 1.71e-04 | 74 | 141 | 5 | int:F2 | |
| Interaction | SPTBN1 interactions | 1.88e-04 | 421 | 141 | 11 | int:SPTBN1 | |
| Interaction | NOL11 interactions | 1.91e-04 | 119 | 141 | 6 | int:NOL11 | |
| Interaction | AR interactions | RAF1 CAND1 MED16 IARS1 RANBP3 POU2F1 DAPK3 IPO4 RREB1 IFI16 ADAR DHX9 BRCA1 SVIL INTS4 DDX23 XRCC6 KDM1A | 1.97e-04 | 992 | 141 | 18 | int:AR |
| Interaction | SRSF7 interactions | RAF1 CAND1 MRPL44 IREB2 DHX9 ACE2 ZNF638 DDX23 USP39 DDX28 XRCC6 | 2.04e-04 | 425 | 141 | 11 | int:SRSF7 |
| Interaction | CLTC interactions | RAF1 CAND1 CLTCL1 IARS1 BAG2 AP3B1 ADAR ACE2 SEC24C BRCA1 AP2A1 SVIL XRCC6 WNK3 | 2.07e-04 | 655 | 141 | 14 | int:CLTC |
| Interaction | TOP3B interactions | CLTCL1 VWA8 IARS1 NICN1 GRK5 IREB2 IPO4 ECE1 BTN3A2 DHX9 IGF2BP2 AATK POMGNT2 AP2A1 XPO6 RPTOR SVIL DLAT TRAPPC9 DDX28 XRCC6 SPATA13 SYNCRIP | 2.20e-04 | 1470 | 141 | 23 | int:TOP3B |
| Interaction | SIRT7 interactions | RAF1 SPAG9 IPO4 IGF2BP2 SEC24C BAZ2A DDX18 NUP210 ZNF638 DDX23 DLAT USP39 XRCC6 KDM1A SYNCRIP | 2.29e-04 | 744 | 141 | 15 | int:SIRT7 |
| Interaction | CIP2A interactions | 2.43e-04 | 176 | 141 | 7 | int:CIP2A | |
| Interaction | ANKFY1 interactions | 2.61e-04 | 236 | 141 | 8 | int:ANKFY1 | |
| Interaction | MRRF interactions | 2.61e-04 | 299 | 141 | 9 | int:MRRF | |
| Interaction | XRCC6 interactions | RAF1 CAND1 RANBP3 BAG2 POU2F1 IFI16 ADAR DHX9 PHF2 ACE2 BRCA1 BAZ2A RPTOR PRIM1 ZNF638 DLAT XRCC6 | 2.69e-04 | 928 | 141 | 17 | int:XRCC6 |
| Interaction | AP1B1 interactions | 2.69e-04 | 237 | 141 | 8 | int:AP1B1 | |
| Interaction | PRMT1 interactions | RAF1 CAND1 FNTA IARS1 IFI16 ADAR DHX9 ACE2 IGF2BP2 SEC24C BRCA1 DDX23 DLAT SAMD3 PLS3 KDM1A SYNCRIP | 2.72e-04 | 929 | 141 | 17 | int:PRMT1 |
| Interaction | PTEN interactions | CAND1 PITRM1 BAG2 BCAR1 IPO4 ADAR RYR3 DHX9 AATK SEC24C RPTOR USP39 MAP2K6 YME1L1 XRCC6 KDM1A GOT1 | 2.72e-04 | 929 | 141 | 17 | int:PTEN |
| Interaction | GRSF1 interactions | RAF1 CAND1 FNTA VWA8 MRPL44 IFI16 DHX9 IGF2BP2 DDX18 GFM1 DDX28 SYNCRIP | 2.75e-04 | 515 | 141 | 12 | int:GRSF1 |
| Interaction | RIPK4 interactions | RAF1 CAND1 ANK2 VWA8 BAG2 IPO4 PNKD ESYT2 IQSEC1 SCFD1 YME1L1 | 3.08e-04 | 446 | 141 | 11 | int:RIPK4 |
| Interaction | PHB1 interactions | RAF1 CAND1 VWA8 IARS1 MRPL44 PNKD IFI16 ADAR DHX9 ACE2 ESYT2 IGF2BP2 DDX18 NUP210 USP39 TMEM41B GFM1 XRCC6 SYNCRIP | 3.15e-04 | 1123 | 141 | 19 | int:PHB1 |
| Interaction | AATF interactions | 3.21e-04 | 376 | 141 | 10 | int:AATF | |
| Interaction | PARP1 interactions | RAF1 CAND1 MRPL44 TOPBP1 POU2F1 DAPK1 IPO4 RREB1 IFI16 ADAR PHF2 ACE2 PPP3CC SEC24C BRCA1 AP2A1 DDX18 SVIL DLAT XRCC6 SYNCRIP | 3.28e-04 | 1316 | 141 | 21 | int:PARP1 |
| Interaction | HNRNPU interactions | CAND1 CLTCL1 GRK5 MRPL44 POU2F1 SPAG9 IFI16 DHX9 PHF2 ACE2 BRCA1 AP2A1 DDX18 DDX23 USP39 TMEM41B HYDIN SYNCRIP | 3.30e-04 | 1035 | 141 | 18 | int:HNRNPU |
| Interaction | LAMP2 interactions | RAF1 FPGS FLVCR1 DAPK1 GPRIN3 CTDSP1 SPAG9 SLC30A6 ESYT2 AP2A1 RPTOR SCFD1 ALDH6A1 | 3.55e-04 | 609 | 141 | 13 | int:LAMP2 |
| Interaction | WDR76 interactions | 3.72e-04 | 383 | 141 | 10 | int:WDR76 | |
| Interaction | BIRC3 interactions | RAF1 CAND1 PITRM1 IARS1 MRPL44 IPO4 AP3B1 ADAR LAP3 DHX9 PHF2 AP2A1 RPTOR DDX18 NUP210 DLAT GFM1 PLS3 XRCC6 KDM1A SYNCRIP | 3.93e-04 | 1334 | 141 | 21 | int:BIRC3 |
| Interaction | TRAPPC2 interactions | 3.93e-04 | 136 | 141 | 6 | int:TRAPPC2 | |
| Interaction | GTPBP10 interactions | 3.93e-04 | 136 | 141 | 6 | int:GTPBP10 | |
| Interaction | GRWD1 interactions | 4.28e-04 | 390 | 141 | 10 | int:GRWD1 | |
| Interaction | RHOT2 interactions | 4.39e-04 | 321 | 141 | 9 | int:RHOT2 | |
| Interaction | HGF interactions | 4.45e-04 | 51 | 141 | 4 | int:HGF | |
| Interaction | EED interactions | CAND1 IARS1 BAG2 DAPK1 IPO4 AP3B1 ADAR DHX9 IGF2BP2 SEC24C BRCA1 AP2A1 BAZ2A DDX18 SVIL NUP210 ZNF638 SCFD1 PLS3 XRCC6 KDM1A SYNCRIP | 4.45e-04 | 1445 | 141 | 22 | int:EED |
| Interaction | COX8A interactions | 4.49e-04 | 322 | 141 | 9 | int:COX8A | |
| Interaction | OGDH interactions | 4.50e-04 | 256 | 141 | 8 | int:OGDH | |
| Interaction | SNAI1 interactions | CAND1 CLTCL1 IARS1 BAG2 CTDSP1 IPO4 DHX9 INTS4 USP39 XRCC6 KDM1A SYNCRIP | 4.65e-04 | 546 | 141 | 12 | int:SNAI1 |
| Interaction | SH3BGRL2 interactions | 4.68e-04 | 22 | 141 | 3 | int:SH3BGRL2 | |
| Interaction | PES1 interactions | 4.74e-04 | 258 | 141 | 8 | int:PES1 | |
| Interaction | GOT1L1 interactions | 4.79e-04 | 5 | 141 | 2 | int:GOT1L1 | |
| Interaction | ALDH9A1 interactions | 4.95e-04 | 93 | 141 | 5 | int:ALDH9A1 | |
| Interaction | ZNF638 interactions | 5.11e-04 | 261 | 141 | 8 | int:ZNF638 | |
| Interaction | PLEKHA2 interactions | 5.20e-04 | 94 | 141 | 5 | int:PLEKHA2 | |
| Interaction | DDX21 interactions | RAF1 CLTCL1 GRK5 IFI16 ADAR DHX9 ACE2 IGF2BP2 BRCA1 DDX18 DDX23 USP39 XRCC6 SYNCRIP | 5.21e-04 | 718 | 141 | 14 | int:DDX21 |
| Interaction | PRKRA interactions | 5.22e-04 | 400 | 141 | 10 | int:PRKRA | |
| Interaction | ZYX interactions | 5.24e-04 | 329 | 141 | 9 | int:ZYX | |
| Interaction | COMTD1 interactions | 5.26e-04 | 200 | 141 | 7 | int:COMTD1 | |
| Interaction | BTN3A1 interactions | 5.36e-04 | 23 | 141 | 3 | int:BTN3A1 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 1.35e-06 | 5 | 94 | 3 | 1021 | |
| GeneFamily | Ankyrin repeat domain containing|BRCA1 B complex | 1.59e-04 | 4 | 94 | 2 | 1335 | |
| GeneFamily | Glycine receptors | 2.65e-04 | 5 | 94 | 2 | 868 | |
| GeneFamily | DEAD-box helicases | 1.35e-03 | 42 | 94 | 3 | 499 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.61e-03 | 163 | 94 | 5 | 590 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 2.69e-03 | 15 | 94 | 2 | 458 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | RAF1 DAPK2 TOPBP1 RREB1 AP3B1 IFI16 ADAR BTN3A1 DHX9 CDY1 ARHGAP4 PPP3CC BRCA1 BAZ2A DDX18 NUP210 SCFD1 PPIP5K2 YME1L1 IL5RA DDX28 NSMAF SYNCRIP | 1.35e-06 | 1394 | 140 | 23 | M9585 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN | 4.00e-06 | 171 | 140 | 8 | M2990 | |
| Coexpression | GSE27786_NKTCELL_VS_ERYTHROBLAST_UP | 1.22e-05 | 199 | 140 | 8 | M4865 | |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN | 1.22e-05 | 199 | 140 | 8 | M6365 | |
| Coexpression | GSE34515_CD16_POS_MONOCYTE_VS_DC_UP | 1.26e-05 | 200 | 140 | 8 | M8765 | |
| Coexpression | GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN | 1.26e-05 | 200 | 140 | 8 | M7686 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | FNTA GPRIN3 IFI16 ADAR BTN3A2 BTN3A1 DHX9 ARHGAP4 ESYT2 PPP3CC USP42 XPO6 NUP210 LPIN2 AGFG1 ZNF638 SAMD3 YME1L1 XRCC6 NSMAF SPATA13 SORL1 | 1.41e-05 | 1492 | 140 | 22 | M40023 |
| Coexpression | IBRAHIM_NRF1_UP | BAG2 SPAG9 ECE1 RYR3 SEC24C DLAT SCFD1 YME1L1 PLS3 XRCC6 SYNCRIP | 1.67e-05 | 420 | 140 | 11 | M42509 |
| Coexpression | LEE_BMP2_TARGETS_DN | IARS1 FPGS FLVCR1 HAUS5 TOPBP1 LRR1 BRCA1 DDX18 AGFG1 EXO1 MEDAG DLAT USP39 GFM1 XRCC6 SYNCRIP | 2.77e-05 | 904 | 140 | 16 | M2325 |
| Coexpression | MANALO_HYPOXIA_DN | 2.86e-05 | 292 | 140 | 9 | M18562 | |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 3.19e-05 | 166 | 140 | 7 | M6701 | |
| Coexpression | LEE_BMP2_TARGETS_DN | IARS1 FPGS FLVCR1 HAUS5 TOPBP1 LRR1 BRCA1 DDX18 AGFG1 EXO1 MEDAG DLAT USP39 GFM1 XRCC6 SYNCRIP | 3.50e-05 | 922 | 140 | 16 | MM1068 |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 3.86e-05 | 171 | 140 | 7 | M5655 | |
| Coexpression | LOPEZ_MBD_TARGETS | RAF1 FNTA MED16 IARS1 GRK5 ARMCX4 MEI1 SVEP1 ITIH3 AATK PPP3CC DDX23 ATP1B2 TRAPPC9 KDM1A GOT1 | 5.19e-05 | 953 | 140 | 16 | M4120 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 5.34e-05 | 180 | 140 | 7 | M8127 | |
| Coexpression | SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP | 6.64e-05 | 79 | 140 | 5 | M14132 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 7.94e-05 | 82 | 140 | 5 | M16458 | |
| Coexpression | RIZ_ERYTHROID_DIFFERENTIATION | 9.42e-05 | 85 | 140 | 5 | MM1106 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP | 1.00e-04 | 199 | 140 | 7 | M8277 | |
| Coexpression | GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN | 1.03e-04 | 200 | 140 | 7 | M3074 | |
| Coexpression | GOLDRATH_HOMEOSTATIC_PROLIFERATION | 1.59e-04 | 150 | 140 | 6 | M3592 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-07 | 184 | 142 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 1.26e-06 | 170 | 142 | 7 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-06 | 172 | 142 | 7 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-06 | 178 | 142 | 7 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.98e-06 | 182 | 142 | 7 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 2.64e-06 | 190 | 142 | 7 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.13e-06 | 195 | 142 | 7 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.13e-06 | 195 | 142 | 7 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 3.24e-06 | 196 | 142 | 7 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 200 | 142 | 7 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 160 | 142 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 160 | 142 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.40e-05 | 163 | 142 | 6 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 169 | 142 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 10x5'-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue | 2.03e-05 | 174 | 142 | 6 | a5838821bba2be790d32331ff529d466e9974268 | |
| ToppCell | 10x5'-blood-Mast|blood / Manually curated celltypes from each tissue | 2.03e-05 | 174 | 142 | 6 | 3a8a253213b207e3ff56f94a74996b8d9ad47aa1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-05 | 178 | 142 | 6 | a0ab20c588e7d43d0320d4779d9ab95c1c86e297 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 181 | 142 | 6 | e4dbc09f0210de465d8347969b301c22463a2b7d | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 184 | 142 | 6 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.78e-05 | 184 | 142 | 6 | bd786db4dc4edae6d5cfc0b69901983dea19f729 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 184 | 142 | 6 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.87e-05 | 185 | 142 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.87e-05 | 185 | 142 | 6 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.05e-05 | 187 | 142 | 6 | a9316e2818217ec5feae9cf8816f7249803caee6 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.14e-05 | 188 | 142 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.14e-05 | 188 | 142 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.23e-05 | 189 | 142 | 6 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 3.53e-05 | 192 | 142 | 6 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.53e-05 | 192 | 142 | 6 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.53e-05 | 192 | 142 | 6 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-05 | 193 | 142 | 6 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-05 | 193 | 142 | 6 | 96c85b250d04b5f400512097d925061c6dc2906b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.64e-05 | 193 | 142 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.64e-05 | 193 | 142 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.64e-05 | 193 | 142 | 6 | cf3cbf79ccd34ddcf06ec6194a18a7afd7f91f39 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.64e-05 | 193 | 142 | 6 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 3.74e-05 | 194 | 142 | 6 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 3.74e-05 | 194 | 142 | 6 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 195 | 142 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.85e-05 | 195 | 142 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 3.85e-05 | 195 | 142 | 6 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 195 | 142 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 196 | 142 | 6 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.96e-05 | 196 | 142 | 6 | 308fa54385ca34e9e590967d4553b84aad96c92f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-05 | 196 | 142 | 6 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 197 | 142 | 6 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.08e-05 | 197 | 142 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.08e-05 | 197 | 142 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 197 | 142 | 6 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.15e-05 | 120 | 142 | 5 | 2b7596946f9268c4202348adf3069decd8313bb0 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.19e-05 | 198 | 142 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.19e-05 | 198 | 142 | 6 | c78ff8fc71dfcba1ac0c373bc90ea7b87c5699a4 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 198 | 142 | 6 | dc6d9032c5029527e184ac13b887c0c1f22ef1c0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.19e-05 | 198 | 142 | 6 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.19e-05 | 198 | 142 | 6 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.31e-05 | 199 | 142 | 6 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.31e-05 | 199 | 142 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | 6f531a418ff25b59a543800cf4bce7b72404ce08 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.43e-05 | 200 | 142 | 6 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 4.43e-05 | 200 | 142 | 6 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | (01)_Cycling_Basal_(homeostasis)-(1)_24hpi|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint | 7.84e-05 | 71 | 142 | 4 | 6aa56b0daaeb5e0ae30619f9c6945c8e42899b27 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 9.24e-05 | 142 | 142 | 5 | 0e0f8bb956ff89dc98e8fa56f8acac33e01a26dd | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.55e-05 | 143 | 142 | 5 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.87e-05 | 144 | 142 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-04 | 147 | 142 | 5 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 148 | 142 | 5 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 148 | 142 | 5 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-04 | 148 | 142 | 5 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 154 | 142 | 5 | a5289000597068ee8d559f89bce7bce31f35dd57 | |
| ToppCell | facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 157 | 142 | 5 | 370f44047ef438b8f1124c2c2761c150c0d8c57f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 161 | 142 | 5 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 161 | 142 | 5 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | droplet-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 163 | 142 | 5 | a794540f2d8984f963c08f05175e4bc916fcc224 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 163 | 142 | 5 | 385b24e18df5ef92108483de312d6c85a1e6d145 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 163 | 142 | 5 | bbc078761c5043af13d9a6fcf3145a3e300bae5e | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-T_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-04 | 163 | 142 | 5 | 8004cc0b3428be08b89957b563cd8799f822d931 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.76e-04 | 163 | 142 | 5 | 8e32b6431e1862572663aa6ddc4ea299c6acc8a6 | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 165 | 142 | 5 | ba041deb0d9c187f251493ccd4794b5f09abd5aa | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-04 | 165 | 142 | 5 | 7c771f22b58989572c939ed127e637ec28dc0dca | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 166 | 142 | 5 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-04 | 166 | 142 | 5 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.97e-04 | 167 | 142 | 5 | 55c3c68af269fcf40f2b080ae4489523609ad388 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.03e-04 | 168 | 142 | 5 | db56464b946ef9795bc41ed1099c864d49bd8900 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 2.03e-04 | 168 | 142 | 5 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.09e-04 | 169 | 142 | 5 | e992530776cab922d0360b275fb9cb8bd0017b06 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-04 | 170 | 142 | 5 | a965e3ee6818790a4a6916824fde64333d9b11b7 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-04 | 170 | 142 | 5 | 10e0912dd0beab5d0bbe2bd49e477b5962687925 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 171 | 142 | 5 | a5634b76476b8b2488a706bbab5141f7bd94631f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-04 | 171 | 142 | 5 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 171 | 142 | 5 | 82de2885c8ce4fb7776da6a0207b3355c0910121 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-04 | 171 | 142 | 5 | 09e653973962fb884878089d281f0947f7a285f6 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-04 | 172 | 142 | 5 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.26e-04 | 172 | 142 | 5 | 8b396d1e9173da104d467e42286379fe07cee257 | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Down 200; 9uM; PC3; HT_HG-U133A | MRPL44 HAUS5 DAPK3 PHF2 AATK AGO4 VCAN NUP210 ZNF606 ALDH6A1 | 4.13e-07 | 196 | 141 | 10 | 4494_DN |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; HL60; HG-U133A | 3.64e-06 | 195 | 141 | 9 | 1783_DN | |
| Drug | AC1L1CMQ | 5.08e-06 | 19 | 141 | 4 | CID000001968 | |
| Disease | pulse pressure measurement | COL6A3 ANK2 CYP20A1 PGBD1 BCAR1 RREB1 MEI1 PNKD SVEP1 ITIH3 RPTOR ZNF638 PPP1R1C HYDIN TRAPPC9 XRCC6 KDM1A RSKR | 7.43e-05 | 1392 | 136 | 18 | EFO_0005763 |
| Disease | emphysema pattern measurement | 8.79e-05 | 19 | 136 | 3 | EFO_0005850 | |
| Disease | X-12125 measurement | 1.26e-04 | 4 | 136 | 2 | EFO_0800707 | |
| Disease | N2,N2-dimethylguanosine measurement | 5.80e-04 | 8 | 136 | 2 | EFO_0021125 | |
| Disease | influenza A (H1N1) | 7.15e-04 | 87 | 136 | 4 | EFO_1001488 | |
| Disease | 22q11 partial monosomy syndrome | 7.43e-04 | 9 | 136 | 2 | C3266101 | |
| Disease | Asymmetric crying face association | 9.26e-04 | 10 | 136 | 2 | C0431406 | |
| Disease | 22q11 Deletion Syndrome | 9.26e-04 | 10 | 136 | 2 | C2936346 | |
| Disease | platelet aggregation | 1.18e-03 | 45 | 136 | 3 | GO_0070527 | |
| Disease | cannabis dependence measurement | 1.42e-03 | 48 | 136 | 3 | EFO_0008457 | |
| Disease | Malignant neoplasm of breast | RAF1 ANK1 ANK2 POU2F1 TACC2 BCAR1 ADAR BTN3A2 BRCA1 DDX18 EXO1 PLS3 SORL1 | 1.42e-03 | 1074 | 136 | 13 | C0006142 |
| Disease | atrial fibrillation (is_implicated_in) | 1.85e-03 | 14 | 136 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | lean body mass | 1.93e-03 | 379 | 136 | 7 | EFO_0004995 | |
| Disease | hypertension (is_implicated_in) | 2.42e-03 | 121 | 136 | 4 | DOID:10763 (is_implicated_in) | |
| Disease | DiGeorge Syndrome | 2.43e-03 | 16 | 136 | 2 | C0012236 | |
| Disease | focal segmental glomerulosclerosis | 2.43e-03 | 16 | 136 | 2 | EFO_0004236 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 2.43e-03 | 16 | 136 | 2 | C0795907 | |
| Disease | Shprintzen syndrome | 2.43e-03 | 16 | 136 | 2 | C0220704 | |
| Disease | Disorder of eye | 3.07e-03 | 212 | 136 | 5 | C0015397 | |
| Disease | Dystonia, Paroxysmal | 3.07e-03 | 18 | 136 | 2 | C0393588 | |
| Disease | DNA methylation | 3.46e-03 | 656 | 136 | 9 | GO_0006306 | |
| Disease | diabetes mellitus | 3.86e-03 | 68 | 136 | 3 | EFO_0000400 | |
| Disease | unipolar depression | GRK5 PGBD1 MEI1 ECE1 BTN3A2 BTN3A1 VCAN SVIL PKHD1 ZNF638 SAMD3 LINC01556 TRAPPC9 | 3.87e-03 | 1206 | 136 | 13 | EFO_0003761 |
| Disease | Cleft palate | 4.35e-03 | 71 | 136 | 3 | HP_0000175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEPIQGVNGVVQYPK | 286 | Q9BYV1 | |
| SEVQIAQLRFPVPKG | 371 | A0FGR8 | |
| NIFGTPEFVAPEIVN | 176 | P53355 | |
| FIQFKKPIVVSVNGP | 376 | Q9Y6F8 | |
| PPVGNIVSFEQKATV | 396 | P13611 | |
| NNKGENIPTVEAPVV | 181 | O00481 | |
| FTAVATNQPPKIFVA | 766 | P56945 | |
| QQVEGEFTQKPGFPK | 1726 | Q9UIF9 | |
| KLVPLVQATFPENAV | 1086 | P16157 | |
| FLGPKSSLDFQVVQP | 3116 | Q8TCU4 | |
| PNPENFVGAGIIQTK | 921 | O95782 | |
| KVANEPVLAFTQGSP | 31 | P30038 | |
| PSVFQQPVIFLGADV | 576 | Q9HCK5 | |
| VPDGIVPKNLTDQFT | 366 | Q9H4D0 | |
| QPQIFAKTQTEAIPG | 321 | Q5H9R4 | |
| FFPEDPVKIVRAQGQ | 26 | Q8IUZ5 | |
| IAAPQNFTPSVIFQK | 1011 | O00203 | |
| VPPIVFVQDKGNAAL | 176 | Q8N0V3 | |
| ILKVVDPTPEQFQAF | 376 | P04049 | |
| AIAPPVFVFQKDKGQ | 11 | Q9H6Z4 | |
| TQPGTVFPLKIAQDF | 146 | Q9Y5E4 | |
| DPQNTVKVQVLYPDG | 856 | Q96HW7 | |
| TKQSNVEVPFFPARV | 71 | P48200 | |
| VKFFVAVPGQVISPQ | 1226 | O60271 | |
| GRDASIPQFKPEIQV | 266 | Q5SQ64 | |
| GVKFNVIPPVAQATV | 346 | Q6GTS8 | |
| VPQVQAVFPEGALTK | 1176 | Q01484 | |
| NANEPPLVFVGKGIT | 271 | P28838 | |
| TNPFPAVEPAVVKFV | 731 | Q8TEM1 | |
| GIDQPPFGIFVVDKN | 91 | P32926 | |
| TIFQFKNKTGPQPVT | 621 | Q9Y5R2 | |
| GNFVGPTIISNVKPN | 396 | Q02252 | |
| PQNVVFDVQIPKGAF | 101 | P19823 | |
| LFGNTFEQPKVLPVI | 301 | Q96L50 | |
| FNVLIQVPPMFQKVG | 2731 | Q8NDA2 | |
| EPGQASQIKVTFQPL | 296 | Q6ZU64 | |
| QPLVAVKFLNVTPNV | 241 | P14415 | |
| VPGADIKVLINFNAP | 831 | Q6DN90 | |
| PAVQLADAQVVFKPL | 2431 | Q2LD37 | |
| PKEGPAVVGQFIQDV | 811 | Q86VP6 | |
| QQPSVGTEIFVGKIP | 156 | O60506 | |
| AVVPKFNALNLPGQT | 691 | Q9Y6F6 | |
| QFVTPADVVSGNPKL | 351 | P13797 | |
| FGIKNFSAIINPPQA | 571 | P10515 | |
| VPKVGTVQVTLFNPN | 421 | Q7L5A3 | |
| FKPVNNADFIIPVEI | 106 | Q9GZU7 | |
| QVPEAFTNPLKVTEG | 776 | Q5H8C1 | |
| NIFGTPEFVAPEIVN | 176 | O43293 | |
| NPKAQLVLVGATFPE | 321 | Q9NUL7 | |
| GVAFDPELLQKQPVN | 361 | Q96LW2 | |
| TEQAKNDPFLVGIPA | 41 | A0A1W2PPG7 | |
| IRPNFKGIPVDVVVN | 71 | P48167 | |
| VIITGPPEAQFKAQG | 476 | Q9Y6M1 | |
| GFVQPQGPKANILVS | 246 | Q8NAT1 | |
| QRKVVPTFEAVAPQS | 426 | O94927 | |
| KVPPFVDLNVNSNEG | 616 | Q9NVP1 | |
| QGFDPPIIIFVNQKK | 661 | Q9BUQ8 | |
| QEAVKNFFPPGNEVV | 171 | Q5VYS4 | |
| TQTNGLDFQKQPVPV | 21 | P14859 | |
| LDFQKQPVPVGGAIS | 26 | P14859 | |
| IFQQISPVVGDKQPT | 321 | Q9Y2X0 | |
| QDQGERPPLVVFKAS | 726 | Q5TIA1 | |
| LQKVDQFDPFTVPTI | 336 | P49642 | |
| NIKPVQTVNITAGFP | 916 | P38398 | |
| VPHGPVDQKFQSIVI | 146 | O95816 | |
| FPVIGAPAQNEIKEV | 211 | Q01638 | |
| FLVNVNGSPEPVKLT | 541 | Q4G0P3 | |
| PGVPEVFKRSFQIQI | 1461 | Q4G0P3 | |
| VGPPAVKEVVNFTCQ | 4626 | Q4G0P3 | |
| LPPVNFTIKVTGLAQ | 31 | Q01344 | |
| FPDIISGPQQTQKVF | 196 | O60341 | |
| KFQVVINGREFPPAE | 536 | P55265 | |
| IFNIIPSTFLPKQEG | 781 | Q9Y6W3 | |
| NIFGTPEFVAPEIVN | 186 | Q9UIK4 | |
| PQVFLQPGQVKFVLG | 231 | O43559 | |
| SGVVPFIFQAKNADP | 966 | P12111 | |
| LTVPFGQKPNIDVTD | 281 | Q9BYF1 | |
| VFAEVPQAQPVLVFK | 6 | P17174 | |
| ISYIPQVIQQFPGKD | 506 | Q68D51 | |
| NAKGENIPAVEAPVV | 181 | P78410 | |
| VELQNGPKAGTFPVN | 36 | Q9Y5Y0 | |
| FKGPPVNVTCNIFIN | 66 | P23416 | |
| EAGPNQTFEVPNKII | 281 | Q16666 | |
| NGYPKPVVQITLQDV | 226 | Q92636 | |
| IFKQGVPAFTVLQPE | 246 | Q05932 | |
| PTKNEIVFPAGILQA | 571 | P42892 | |
| INQVFGNGPVTPEKI | 306 | Q6UW02 | |
| PGVFNEVQKAPATFN | 81 | Q6ZVF9 | |
| TPKSPVFIAQVGQDL | 111 | P34947 | |
| SNIPKQFVPAVEKGF | 576 | Q96RP9 | |
| GVFKPNQQTVLLPES | 236 | Q9UNA4 | |
| GQVPPLVTTNFLVKD | 351 | P53992 | |
| ALENFVENLGPKVQP | 461 | Q8TEX9 | |
| QEGNPAPFIINTVKR | 6 | Q5JQF7 | |
| VPVALNIGKLAQFEP | 306 | Q08211 | |
| VKPPQGENVFFLVTN | 101 | O15547 | |
| GTPFQQLKQVVEEPS | 261 | P52564 | |
| QVKGSLALPFPADVQ | 416 | Q14D33 | |
| EAPPEGTVNVFVKTQ | 2326 | O75445 | |
| VPPAVLQQTFFAVIG | 186 | Q9H9J2 | |
| QPEPIKVYGQVSLND | 86 | Q92673 | |
| FNGVKVLPIPVLSDN | 116 | Q8N490 | |
| APDVKPVQNGSQLFI | 76 | O75151 | |
| NFFVEKNPTIVNFPI | 461 | Q53GS9 | |
| EQVQSGKLIPFSPAV | 861 | O95425 | |
| FPPQLVVQKGLVAIQ | 151 | Q9C0I9 | |
| VVPAFRSLQKQVGTP | 886 | Q6ZMQ8 | |
| QVQVSTPVLEVKNPF | 426 | Q8N6K7 | |
| QGLPVVPKNVAFVID | 276 | Q06033 | |
| NDGPNPVVQIIYSDK | 81 | P49354 | |
| PKKIQFAVPVFQSQI | 6 | Q8WVI7 | |
| EELQIYQQGPKSPSV | 131 | Q9BSH3 | |
| DPQTPLVFKGVVFNE | 191 | Q5JRX3 | |
| SFPEEPSQVQLKGVQ | 2191 | P08F94 | |
| TALFGQPPFKNVIVN | 576 | P41252 | |
| QPPFKNVIVNGLVLA | 581 | P41252 | |
| DKAVVPVFNPVRSQT | 201 | Q96JS3 | |
| PPAIKDAVITGNNFT | 1966 | Q4LDE5 | |
| SEVFVPDLVNGPTNK | 456 | Q9UQ84 | |
| KFIQSSGQPVPLVVE | 511 | P98171 | |
| QIFLNRNPGVPSVVK | 1016 | Q8N122 | |
| PQEVTLKPGNGTVFV | 351 | Q8WZ75 | |
| QTKPVVTPFGQVAAA | 521 | P52594 | |
| IEVGQPAAGNQPFVK | 231 | P53675 | |
| PAAGNQPFVKKAVDV | 236 | P53675 | |
| SVPQQQVFGLAEPKR | 621 | Q96N96 | |
| PPTQRLTFKEVFENG | 21 | P48454 | |
| DDQKIQVTPPGFQLV | 421 | P12956 | |
| VVTNKQAAPGFIGPQ | 441 | Q9H9J4 | |
| DIVPVKENFNPTTGI | 181 | Q86XK7 | |
| PFQKGFIIQPDSSIV | 441 | Q92766 | |
| QVEPNTKVFPAVFLQ | 1436 | Q15413 | |
| VPRNKNPFQEAIVFV | 581 | Q8WVM8 | |
| TAEVEKPAGLLFQQP | 2731 | O95359 | |
| KQLGIPTANFPEQVV | 21 | Q969G6 | |
| KPNEGVIIIGATNFP | 471 | Q96TA2 | |
| EFSFNTPGKNVNPVI | 386 | Q6NXT4 | |
| AQFPLQPGKVATFTI | 776 | Q96Q05 | |
| NGEVFQKPFVEKPVS | 176 | O43314 | |
| NITSPVINVPLKVFF | 216 | Q5BJD5 | |
| LQVVVQEPGQVFKPF | 896 | Q96QU8 | |
| NVPEPILQKLVAAFG | 946 | A3KMH1 | |
| QVAASPAVGQPLQKE | 801 | Q92547 | |
| LFQPFGKVNDVLIVP | 696 | Q14966 | |
| TGLPAAQVQEPVTFK | 51 | Q8WXB4 | |
| PNGIFPQLFQSTIKD | 2091 | Q9P2D8 | |
| QQVTLPAIPSKGVFL | 1236 | Q9Y493 | |
| KPDGISFENRVPQVA | 16 | Q9BYP7 | |
| QVGVPDCRIFTVNPK | 821 | Q92539 |